Press release
Non-alcoholic Steatohepatitis (NASH) Biomarkers Market 2021 Global and Clinical Research - Biopredictive, Quest Diagnostics, Exalenz Bioscience, GENFIT
Global Non-alcoholic Steatohepatitis (NASH) Biomarkers market reports provide a detailed analysis of area market expansion, competitiveness, global and regional market size, and growth analysis. It also offers recent developments such as market share, opportunity analysis, product launch and sales analysis, segmentation growth, market innovation and value chain optimization, and SWOT analysis. The latest reports on the Non-alcoholic Steatohepatitis (NASH) Biomarkers market cover the current impact of COVID-19 on the market. This has brought about some changes in market conditions. Early and future assessments of rapidly changing market scenarios and impacts are covered in the report.Request Sample Copy of Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Research Report:
https://www.marketinsightsreports.com/reports/04192809303/global-non-alcoholic-steatohepatitis-nash-biomarkers-market-growth-2021-2026/inquiry?Mode=11
Top Leading Companies of Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market are Biopredictive, Quest Diagnostics, Exalenz Bioscience, GENFIT, Siemens Healthineers, ONE WAY LIVER, Prometheus Laboratories, Gilead Sciences and others.
Industry Update:
June 2019: High Joint Clinical Trials Center recently announced a 3-year collaboration with ProSciento as a site partner for NASH PASS. NASH PASS is a program by Prosciento which combines select qualified sites and proprietary methodology to enhance enrollment outcomes in nonalcoholic steatohepatitis clinical trials.
June 2019: DILIsym recently announced its release of NAFLDsym, which is a quantitative systems pharmacology (QSP) modeling software to support the development of various treatments for non-alcoholic fatty liver disease/ non-alcoholic steatohepatitis.
Overview:
Non-Alcoholic Steatohepatitis Biomarkers Market is a non-alcoholic greasy liver infection where the liver is essentially harmed because of a development of fat in it. By and by, there is no single supported analysis test for non-alcoholic steatohepatitis. Biomarkers are alluded to as a pointer used to quantify the seriousness of or the presence of a sickness. Thus, non-alcoholic steatohepatitis (NASH) biomarkers are utilized to quantify the seriousness and event of liver irritation caused on account of fat testimony in the liver.
Rise in Demand for Non-invasive Diagnostics to Drive Global Market
Liver biopsies are the gold standard in diagnosis and monitoring of NASH in the absence of any alternative diagnostic tools. Liver biopsy is a painful procedure for most patients; bleeding occurs in most cases. The mortality rate associated with liver biopsy stands at one in 10,000. Furthermore, liver biopsies are not entirely accurate, for the diagnosis of the NASH condition. These drive the need of developing non-invasive diagnostic techniques, which includes novel biomarkers for diagnosis and routine monitoring of NASH. Various key players in the pharmaceutical and biotechnology industries are investing in this field. The NASH therapeutics market is projected to reach US$ 35 Bn to US$ 40 Bn by 2024.
On The Basis Of Product, Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Is Primarily Split Into:
Serum Biomarkers
Cytokeratin-18 (CK 18) Marker
Inflammatory Markers
Others
On The Basis Of End Users/Application, This Report Covers:
Hospitals
Diagnostic Centers
Others
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Non-alcoholic Steatohepatitis (NASH) Biomarkers market in 2021.
Points Covered in The Report:
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
Browse Full Report at:
https://www.marketinsightsreports.com/reports/04192809303/global-non-alcoholic-steatohepatitis-nash-biomarkers-market-growth-2021-2026?Mode=11
What Are The Market Factors That Are Explained In The Report?
Market Players and Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 and Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume and revenue forecast.
Market Trends: Non-alcoholic Steatohepatitis (NASH) Biomarkers Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Developments.
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
We Offer Customization On Report Based On Specific Client Requirement:
– Country Level analysis for any 5 countries of your choice.
– Competitive analysis of any 5 key market players.
– 40 analyst hours to cover any other data point.
Related Reports:
Global Serum Biomarkers Market 2020 By Manufacturers, Regions, Type And Application, Forecast To 2025
https://www.marketinsightsreports.com/reports/05282050962/global-serum-biomarkers-market-2020-by-manufacturers-regions-type-and-application-forecast-to-2025?Mode=11
Global Cytokeratin 19 Fragment Quantitative Determination Kit Market Research Report 2021
https://www.marketinsightsreports.com/reports/04012766319/global-cytokeratin-19-fragment-quantitative-determination-kit-market-research-report-2021?Mode=11
Contact US:
Irfan Tamboli (Head of Sales): Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com
ABOUT US:
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-alcoholic Steatohepatitis (NASH) Biomarkers Market 2021 Global and Clinical Research - Biopredictive, Quest Diagnostics, Exalenz Bioscience, GENFIT here
News-ID: 2294211 • Views: …
More Releases from Market Insights Reports
Cold Chain Monitoring Market May See a Big Move | BlueAir, Denso, Eureka Forbes, …
Market Insights Reports published a new research publication on "Cold Chain Monitoring Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Cold Chain Monitoring market was mainly driven by the increasing R&D spending across the world.
Some of the key players…
Outbound Logistics Market Next Big Thing | Major Giants- Draexlmaier, Faurecia, …
Market Insights Reports published a new research publication on "Outbound Logistics Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Outbound Logistics market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
Veterinary Telemedicine Market May See a Big Move | Nestle, Deuerer, The J.M. Sm …
Market Insights Reports published a new research publication on "Veterinary Telemedicine Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Veterinary Telemedicine market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
Precision Planting Market is Set to Fly High in Years to Come
Market Insights Reports published a new research publication on "Precision Planting Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Precision Planting market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
More Releases for NASH
Nonalcoholic Steatohepatitis (NASH) Market Massive Growth opportunity Ahead
Introduction
Nonalcoholic Steatohepatitis (NASH) is an advanced form of nonalcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the liver along with inflammation and liver cell damage. If left untreated, NASH can progress to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma. Closely tied to the global obesity and diabetes epidemic, NASH has become a major healthcare burden, with millions affected worldwide and no widely approved curative therapy to date.
The NASH…
Non-Alcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2023
Nonalcoholic steatohepatitis (NASH) is a type of fatty liver disease. It is characterized by the accumulation of fat in the liver, inflammation, and damage. NASH can lead to cirrhosis, liver failure, and death. The exact cause of NASH is unknown, but it is believed to be associated with obesity, insulin resistance, and diabetes. Treatment of NASH is focused on weight loss, exercise, and the control of diabetes and insulin resistance.
NASH…
Non Alcoholic Steatohepatitis (NASH) Market Size to Hit $21,879 Million by 2028 …
According to our experience research team, Non Alcoholic Steatohepatitis (NASH) Market was valued at USD 1,569 Million in 2021, and the global Non Alcoholic Steatohepatitis (NASH) industry is projected to reach a value of USD 21,879 Million by 2028, at a CAGR of 60.4% during the forecast period 2022-2028
The report is focused on gaining various Non Alcoholic Steatohepatitis (NASH) market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining…
NASH Market Insight and Landscape report
Report Snapshot:
NASH is one of the furthermost causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming years, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NASH vary across different country level. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their…
Nash releases debut EP 'She Don't Know'
London-based singer/songwriter Nash has released his debut EP She Don’t Know. Recorded at the legendary RAK Studios, She Don’t Know has the feel of 60s rock but with a modern twist, leaving the listener hooked throughout and wanting to come back for another listen. She Don’t Know’s leading single CK is an infectious number which is sure to be a hit for 2017.
Listening to the Beatles and Jack White growing…
Nash Technologies at GITEX/GULFCOMMS 2010
Harvey Nash subsidiary presents expert services to telecom operators in the Middle East, Africa and South Asia region
Nürnberg/Germany, 10th September 2010 – For the first time Nash Technologies will be present at GITEX/GULFCOMMS, the largest international trade event for mobile, fixed, IP and satellite communications for the Middle East, Africa and South Asia region, in Dubai from 17th to 21st October 2010 offering its telecom expert services. Nash Technologies will…
